X0306 4 2022-01-20 0 0001642545 Shockwave Medical, Inc. SWAV 0001602773 PUCKETT DAN C/O SHOCKWAVE MEDICAL, INC. 5403 BETSY ROSS DRIVE SANTA CLARA CA 95054 0 1 0 0 Chief Financial Officer Common Stock 2022-01-20 4 M 0 750 4.03 A 45338 D Common Stock 2022-01-20 4 M 0 750 17.00 A 46088 D Common Stock 2022-01-20 4 S 0 318 141.21 D 45770 D Common Stock 2022-01-20 4 S 0 100 144.40 D 45670 D Common Stock 2022-01-20 4 S 0 300 146.87 D 45370 D Common Stock 2022-01-20 4 S 0 400 148.10 D 44970 D Common Stock 2022-01-20 4 S 0 200 148.92 D 44770 D Common Stock 2022-01-20 4 S 0 182 149.99 D 44588 D Stock Option 4.03 2022-01-20 4 M 0 750 0.00 D 2028-07-19 Common Stock 750 1509 D Stock Option 17.00 2022-01-20 4 M 0 750 0.00 D 2029-03-06 Common Stock 750 17997 D All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.73 to $141.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The reported securities were sold at a price of $144.40. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $146.60 to $147.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $147.69 to $148.57. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $148.80 to $149.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $149.90 to $150.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. /s/ Wade Estey, as attorney-in-fact for Dan Puckett 2022-01-21